WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, announced today that the Company will report its fourth quarter and full year 2006 financial results after the U.S. Financial Markets close on Wednesday, February 21, 2007. Following the announcement, Panacos will hold a conference call to discuss the results and provide an update on the Company’s development programs. Alan W. Dunton, M.D., Chief Executive Officer will host the call.
